US Stock Market Move | Regencell Bioscience Holdings Ltd. (RGC.US) has risen by more than 47%, and has risen by more than 6246% since the beginning of the year.
As of press time, the stock has risen more than 47%, reporting at $313.54.
On Friday, the stock price of Regencell Bioscience Holdings Ltd. (RGC.US) soared, reaching $313.54 by the time of publication, an increase of over 47%. The stock has risen over 6246% year-to-date. Regencell Bioscience Holdings Ltd. is an early-stage biotechnology company focused on the research and commercialization of traditional Chinese medicine for the treatment of neurocognitive disorders and degenerative changes, specifically ADHD and ASD.
Related Articles
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
